Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Frizzera, 1981, Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients, Cancer Res, 41, 4262 Starzl, 1984, Reversibility of lymphomas and lymphoproliferative lesions developping under ciclosporine steroid therapy, Lancet, 1, 583, 10.1016/S0140-6736(84)90994-2 Grant, 1996, The international intestinal transplant registry: Current results of intestinal transplantation, Lancet, 347, 1801, 10.1016/S0140-6736(96)91619-0 Zutter, 1988, Epstein–Barr virus lymphoproliferation after bone marrow transplantation, Blood, 72, 520, 10.1182/blood.V72.2.520.520 Ho, 1988, The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children, Transplantation, 45, 719, 10.1097/00007890-198804000-00011 Shapiro, 1988, Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation, Blood, 71, 1234, 10.1182/blood.V71.5.1234.1234 Garrett, 1993, Posttransplantation lymphoproliferative disorders treated with cyclophosphamide– doxorubicin-vincristine-prednisone chemotherapy, Cancer, 72, 2782, 10.1002/1097-0142(19931101)72:9<2782::AID-CNCR2820720941>3.0.CO;2-H Shapiro, 1988, Treatment of B-cell lymphoproliferative disorders with interferon-alfa and intravenous gamma globulin, N Engl J Med, 318, 1334, 10.1056/NEJM198805193182013 Pirsch, 1989, Treatment of severe Epstein–Barr virus induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation, Am J Med, 86, 241, 10.1016/0002-9343(89)90279-9 Papadopoulos, 1994, Infusion of donor leukocytes to treat Epstein–Barr virus associated lymphoproliferative disorders after allogeneic bone marrow transplantation, N Engl J Med, 330, 1185, 10.1056/NEJM199404283301703 Rooney, 1995, Use of gene modified virus specific T lymphocytes to control Epstein–Barr virus related lymphoproliferation, Lancet, 345, 9, 10.1016/S0140-6736(95)91150-2 Fischer, 1991, Anti B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation, N Engl J Med, 324, 1451, 10.1056/NEJM199105233242102 Benkerrou, 1998, Anti B-cell monoclonal antibody treatment of severe post transplant B lymphoproliferative disorder: Prognostic factors and long-term outcome, Blood, 92, 3137, 10.1182/blood.V92.9.3137 McLaughlin, 1998, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program, J Clin Oncol, 16, 2825, 10.1200/JCO.1998.16.8.2825 Haque, 1998, Reconstitution of EBV-Specific T-cell immunity in solid organ transplant recipients, J Immunol, 160, 6204